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Summary.-A comparison has been made of the immunological properties of CEA
(carcinoembryonic antigen) and another perchloric acid-soluble macromolecule
which occurs in colonic and certain other carcinomata and which is here termed CEX.
By using a variety of antisera it was shown that the two substances share common
antigenic groups as well as having characteristic ones of their own. These latter
groups have enabled the preparation of (a) antisera which give a gel diffusion line
only with CEA and (b) an antiserum which gives a line only with CEX. No immuno-
logical difference could be found between CEX and the NGP of Mach or the NCA of
von Kleist and Burtin. CEX was found in foetal gut, in plasma and associated with
CEA in virtually all the tissues and fluids in which the latter occurs; the two appear
to go hand-in-hand and no proof was found that CEX is either less or more cancer
specific than CEA-it is merely found in greater quantity; neither substance showed
absolute cancer specificity. The usefulness of a radioimmunoassay for CEX is
discussed, and also the possibility of interference by CEX in the radioimmunoassay
for CEA. Evidence of two molecular species of CEA has been found.
SINCE Gold and Freedman (1965)
first reported the existence of a glyco-
protein antigen (CEA) in extracts of carci-
nomata of the colon and in the normal
colon of human foetus of the first two
trimesters of pregnancy, several authors
have reported the existence of an associ-
ated protein antigen in these and other
tissues which has been regarded, ingeneral,
as a more normal constituent of colon and
certain other adult tissues. This protein
has been given various names (NGP or
normal glycoprotein, by Mach and Pusz-
taszeri, 1972; NCA or nonspecific cross-
reacting antigen, by von Kleist, Chavanel
and Burtin, 1972; Kleinman, Harwell and
Turner (1971) report a similar protein),
and it is not certain that they all refer to
the same substance, although this is likely
because of its striking relationship with
CEA. Indeed, its existence was suggested
in Gold's original publication.
Our purpose was to study these two
substances and their relationship further,
using immunological methods. Parti-
cular attention was paid to the " associ-
ated" protein provisionally called CEX,
since there was a possibility that a com-
parison of its concentration with that of
CEA in a given extract or blood might
enhance the value ofthe information given
by CEA assay.
MATERIALS AND METHODS
Antisera.-Perhaps the most important
part of this work was the preparation and
comparison of various anti-CEA and anti-
CEX (the CEA-associated protein) antisera.
They were prepared by means of 3 injections
of the antigen in complete Freund's adjuvant
subcutaneously in the back, usually intra-
scapularly. The interval between the first and
second injections wvas 2-4 weeks, and betweenD. A. DARCY, C. TURBERVILLE AND R. JAMES
the second and third 4-5 wecks.The first bleed
was made about 2 weeks after the third
injection. All bleeds wN-ere from the mar-
ginal ear vein of rabbits and from the jugular
vein of goats. Occasionally a booster dose
was given. The followNing antisera Awere
made: (1) anti-saline extract of a human
primary carcinoma of the colon made in 2
rabbits. The extract had 8 8 mg of protein
per ml and each rabbit received 2-5 ml per
injection; (2) anti-perchloric acid (PCA)
extract of the same primary carcinoma of the
colon in 2 rabbits. Each rabbit received
3-2 mg ofthe lyophilized extract perinjection;
(3) anti-PCA extract of a secondary colon
carcinoma metastasis in the liver. The
dose was 5 mg of the lyophilized extract per
injection in 2 rabbits and 2-5 mg in another 2
rabbits; (4) anti-purified CEA prepared in
5 goats (one Gotenburg, 4 Irish mountain
goats), each receiving 10 jug per injection
according to Todd's method (Egan et al.,
1972); (5) anti-purified CEA prepared in 2
rabbits, each receiving 1 ,ug per injection;
(6) anti-CEA prepared in 2 rabbits by
injecting CEA-antibody precipitate lines cut
from an Ouchterlony plate containing 155%
I.D. agar gel. The precipitates were well
washed in saline; (7) an anti-CEX prepared
from the gel precipitates as for the preceding
antiserum in 2 rabbits; (8) anti-CEX pre-
pared in 2 rabbits by injecting the eluate of
the perchloric acid extract of the same colon
cancer used for antiserum No. 3 above, after
treatment with an immunoadsorbant pre-
pared by cross-linking the proteins of a goat
anti-CEA serum with gluteraldehyde (Avrea-
mas and Ternynck. 1969). Each rabbit
received the equivalent of about 0-5 mg of
the original extract per injection. This
eluate w-as free of CEA, as shown by the ring
test. Later, 2 more rabbits were injected
with a similarly treated eluate which had been
found to be CEA-free by radioimmunoassav;
(9) anti-CEX prepared in 2 rabbits by inject-
ing on each occasion 1 mg of a semi-purified
CEX (1/41G) wNhich originated from a colon
carcinoma extract and was fractionated on
Sepharose and Sephadex columns (see Turber-
ville et al., 1973); (10) aniti-CEX prepared
in 2 Salem goats injected oni each occasion
with 10 jug of the semi-purified CEX (1/41G).
Absorption of antisera.- Most anti-sera
contained antibodies to human plasma
proteins and these were removed by stepwise
absorption w-ith a pooled plasma from 10
donors, representing all major blood gr-oups
obtained from the National Blood Trans-
fusion Centre. Next, antibodies to normal
tissue antigens were removed by absorption
with saline extract of normal human colon
following Gold's procedure. These extracts
show-ed little or no CEA or CEX by immune
diffusion. Antisera types 4, 5, 6 and 7
required no absorption.
Antigens. The principal antigens used
in vitro were the perchloric acid extract of
colon cancer metastatis in the liver used in
(3) above (to be referred to as PCAS), and the
purified CEA preparation made bythe method
of Todd (Coligan et al., 1972). This involved
gel filtration ofthe PCA extract on Sepharose
4B and then on Sephadex G200, the active
fractions being detected with anti-CEA (4);
CEX was prepared similarly but came off the
columns in a different peak and was detected
by antiserum No. 3 (Turberville et al., 1973).
Plasma was concentrated for testing by preci-
pitating 5 ml with 1 rnol/l perchloric acid,
lyophilizing the water-dialysed supernatant
and dissolving the resulting few mg ofpowder
in 25 or 50 ,al of saline. In some instances,
the lCD (immune complex development)
technique (Darcy, 1972) was employed to
confirm the identity of very weak lines; this
simply involved washing the gel free ofsoluble
protein and then diffusing anti-rabbit IgG (or
anti-goat, if appropriate) from a central well.
Immmunological methods.-Double diffusion
was carried out in 5-cm plastic petri dishes
containing 1 mm of 1-5% agar gel in phos-
phate-buffered saline (pH 7). WTells were
normally 5 mm in diameter with a distance
betw-een antigen and antibody wvells (edge to
edge) of 1 5, 3 or 5 mm. The method of
Scheidegger (1955) was used for immuno-
electrophoresis.
Quantitation of tissue extracts and body
fluids. The concentration of CEA and CEX
in these wAas estimated semi-quantitatively
by a modification ofthe quantitative Ouchter-
lony plate (Darcy, 1961). Our extract
PCAS was taken as standard and arbitrarily
assigned ++ + " for both CEA and CEX
(of which it appeared to have approximately
equal concentrations). All other extracts
were compared with this extract using 5-mm
diameter wells (holding about 20 ,u) at a
distance of 3 mm from the antiserum well.
Extent of line migration (the measure of its
antigen concentration) was compared by eye
wvith that of the standard.
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TABLE I. Antisera Raised Against CEA and CEX by VarioUs Methods.
were Those Obtained After Appropriate Absorptions*
Nuinber
2
3
4
5
Ii
7
8
9
1 ()
Host
Rabbit
Rabbit
Rabbit
Goat
Rabbit
Rabbit,
Rabbit
Rabbit
Rabbit
Goat,
Immunogen
Saline extract of primary colonic
carcinoma
PCA extract of primary colonic
carcinoma
PCA extract of metastatic colonic
carcinoma
Purified CEA
Purified CEA
CEA gel-precipitate lines
CEX gel-precipitate lines
CEX purified by immuno-absorption
CEX purified by column fractionation
CEX purified by column fIactionation
Antibodies to
Dose
level CEA CEX
mg + +
Results
One or 2
I.D. lines
with
PCASt
One
mg + + OIne
mg + + Two
mg mg
mg
mg
mg
mg
ug
+
+
()
+
t
Onie
Oine
One
Equivocal
One
One
One
* See AMethods.
t l'CA extract of colonic carcinoma metastases.
RESULTS
Properties ofthe vario8usly-prepared antisera
(Table 1)
(1) Rabbit antisera to saline extracts of
primary colon carcinoma. These antisera
were unsatisfactorily weak, requiring con-
centration before use, probably because
the original tumour extract was weak in
CEX and particularly in CEA. After
absorption they yielded a single line in gel
diffusion with tumour extracts. When
purified CEX and CEA were run simul-
taneously against them each antigen
gave a single line which met the other in a
reaction of identity.
(2) Rabbit antisera to PCA extracts of
primary colon carcinoma. These proved
identical to the above (Type 1) but were
somewhat stronger.
(3) Rabbit antisera to PCA extracts of
secondary colon carcinoma.-These were
the most interesting and useful antisera
and have proved ofvalue in estimating the
relative amounts of CEA and CEX in
column fractions using a modification of
Darcy (1-961). After absorption they
yielded two strong Ouchterlony lines with
the extract which gave rise to them
(PCAS), the slower-diffusing of which
was shown to be CEA while the faster-
moving line was ascribed to the unknown
antigen which was called CEX (Fig. 1A).
The second important property of
these antisera was that their CEA and
CEX lines both gave a reaction of identity
with the single line obtained with purified
CEA (Fig. IB). The absence of
" spurring " of the CEX line suggested
that the CEA molecules not only shared
antigens with CEX but that, so far as
these antisera could indicate, CEX had no
peculiar antigenic groupings; this was
later disproved by other antisera (see
below). When CEX was substituted for
CEA in the configuration shown in Fig.
1B it produced a single line which gave an
identity reaction only with the faster-
diffusing line.
By means of these (Type 3) antisera it
was shown that samples of CEA from
various sources (the laboratories of Gold,
Todd, our own, and other workers) gave
reactions of identity but that traces of
contaminants were revealed in most of
them when the antisera were used in the
unabsorbed state.
It is of interest that the two rabbits
which received the smaller antigen dose
gave less useful antisera in that their CEX
and CEA lines were hardly separable
(indicating a higher ratio of anti-CEX
to anti-CEA) and they had more extra-
neous antibody to be absorbed.
(4) Goat anti-purified CEA. A single
line was obtained in gel diffusion with
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FIG. 1.-Ouchterlony plates showing reactions of various CEA and CEX preparations with various
antisera.
A. Perchloric acid extract of a secondary colon carcinoma (PCAS) gives 2 lines with an antiserum
(Type 3) to itself, whether unabsorbed (top left) or absorbed (top right). It gives a single
line with anti-CEA (Type 4) which shows a reaction of identity with the slower diffusing line
which was therefore called the CEA line while the other was called the CEX line. Absorption
of anti-PCAS made little difference.
B. Purified CEA gives a reaction of identity with both the CEA and CEX lines.
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purified CEA and with the crude PCA
tumour extract (PCAS). No line was
obtainable with CEX. However, later
in immunization, after a booster dose of
1 lig of CEA, 2 of the 5 goats developed
a CEX line; this was faint in one but
moderately strong on the other (the
Gotenburg goat). The identity of this
CEX line (which diffused ahead of the
CEA line) was confirmed not only by a
reaction of identity but also by the use of
CEX and monospecific anti-CEX serum
(Type 10).
An early antiserum (3G1) from one
of the Irish goats gave a double CEA line
(with both purified CEA and with PCAS)
and which byits cross-reactions withothers
of these goat anti-CEA sera strongly
suggested that they also would demon-
strate this phenomenon given the correct
antigen-antibody ratio (Fig. 2A). None
of these antisera gave a CEX line. A
later (purer) CEA preparation, made by
" cutting " the column peaks ofCEA more
narrowly, showed the same 2 CEA lines
but much closer together and with their
positions reversed. This indicated that
the faster diffusing component had been
reduced in concentration.
(5) Rabbit anti-purified CEA. When
bled 2 weeks after the last injection one
ofthe resulting sera gave no line with CEX
or CEA, but the second gave a line with
CEA and not with CEX, thus appearing
equivalent to the goat anti-CEA (Type 4).
(6) Rabbit anti-CEA gel precipitate
lines. These antisera were weak. The
stronger showed essentially a reaction of
identity between CEX and CEA (which
here gave a double line) but there was a
faint CEA " spur " indicating some speci-
fic anti-CEA antibodies. The 2 CEA
lines given by this antiserum were com-
pared with those given by antiserum 3G1
(Type 4 above), but it was impossible to
be certain that they were the same, even
though there was an overall reaction of
identity.
(7) Rabbit anti-CEX gel precipitate
lines.-Both antisera were weak but the
stronger one, when concentrated about 10
11
times, was found to have antibodies to
CEA as well as to CEX. The presence of
specific anti-CEX antibodies was indicated
by a " spur".
(8) Rabbit anti-CEX (CEX purified by
immunoabsorption).-These antisera all
had antibodies to CEA as well as to CEX.
One of the 2 antisera prepared against
the CEX which had been found CEA-free
by radioimmunoassay showed the CEX
line giving a spur over the CEA line but
not vice versa, thus indicating the presence
of specific anti-CEX antibody.
(9) Rabbit anti-CEX (CEX purified by
column fractionation).-Antisera from
both rabbits had antibodies to CEA as well
as to CEX and gave a clear-cut " reaction
of partial identity " between the 2 anti-
gens, the CEX line showing a spur past
the CEA line, again indicating the presence
of specific anti-CEX antibodies but no
specific anti-CEA ones.
(10) Goat anti-CEX (CEX purified by
columnfractionation).- The only difference
in procedure from No. 9 was that the
goats received ,ug quantities ofthe antigen
compared with mg amounts injected into
the rabbits. Antiserafrom both goats gave
several lines. In one goat these lines
were found by absorption to be produced
entirely by impurities in the CEX prepara-
tion. However, absorption of the anti-
serum from the other goat with plasma
and normal colon left antibodies which
reacted with CEX (to give a single line)
but not with CEA at any concentration.
The goal of producing a monospecific
anti-CEX antiserum had apparently been
achieved.
Absorption studies
These are summarized in Table II.
Type 3 antiserum (anti-PCAS) was further
absorbed with purified CEA, purified CEX
and the crude PCAS. As would be
expected, no lines were obtained with the
antiserum after absorption with PCAS or
CEA (which reacted with the anti-CEX
antibodies (Fig. IB). Absorption with
purified CEX removed the CEX-line and
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FIG. 2.-A. Purified CEA gives 2 lines with goat anti-CEA (1) and suggestively with anti-CEA from
goats (2) and (3). All are Type 4 antisera.
B. CEX gives a reaction ofpartial identity with CEA ifan unabsorbed " impure " Type 4 anti-CEA
is employed (left) but not when the antiserum is absorbed with normal colon PCA extract
(right).
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TABLE II.-Results of Absorption of Antisera and Antigens
Substance absorbed
Antiserum Type 3
(anti-CEX, anti-CEA)
Absorbant
CEA
CEX
PCAS*
Substances removed by
A
Moderate Massive
absorption absorption
a'CEX and a'CEA
a'CEX only a'CEX and a'CEA
a'CEX and a'CEA
Antiserum Type 4
(anti-CEA)
Antiserum Type 10
(anti-CEX)
PCAS
PCA normal colon 1
PCA normal colon 2
PCA normal colon 3
CEX
a'CEA
a'CEA
a'CEA
Little or no effect
CEA
CEA, including its
CEX-reactivity
Little or no effect
CEA contaminant
and some CEX
CEA
Some CEX
Some CEA
All CEX
All CEX and CEA
All CEX, some CEA
* PCA extract of eolonic carcinoma metastases.
left the CEA line slightly weakened.
Massive absorption with CEX removed the
CEA line also; this was not a dilution
effect. The reasons for it are discussed
below.
Type 4 antiserum (anti-CEA, no anti-
CEX) was absorbed completely by PCAS
and also by massive amounts of CEX
preparations (all of which contained
traces of CEA). We attempted to see if
absorption by PCA extracts of normal
colon would remove an anti-normal com-
ponent and leave a specific anti-cancer
CEA. Three different "normal" colon
PCA extracts were employed which con-
tained differing amounts of CEA and CEX
(Table III). The strongest was an
autopsy specimen which contained CEA
and CEX at 1/20 and 1/10 respectively of
the level in our tumour extract PCAS. The
next strongest was from the uninvolved
colon of patients with colonic carcino-
mata. Absorption with either of these
extracts removed all antibody activity,
whereas absorption with the weak third
extract (also from colon carcinoma
patients) merely weakened the CEA line.
It is apparent therefore that the outcome
of the absorption can be determined by
the selection of the absorbing "normal"
extracts. It is also of some interest that
we were unable to find a PCA extract of
"normal" colon which was completely
free of CEA and CEX. We could readily
produce the picture obtained by Mach and
Pusztaszeri (1972) by using an impure
anti-CEA, i.e., one of our goat anti-CEA
which contained some anti-CEX, before
and after absorption with the "weak"
colon extract (Fig. 2B). This confirms
the correctness ofthe view ofthese authors
that it is necessary to absorb this type of
antiserum with an extract of normal
colon.
Type-10 antiserum (anti-CEX) could
be absorbed only by massive amounts of
CEA. A faint CEX line was still obtained
at the technical limits.
Absorption of purified CEA by anti-
CEA had as its purpose to see if any of its
CEX reactivity (Fig. iB) would remain;
it did not. Nor was it possible to demon-
strate any CEX in purified CEA by the
most sensitive gel methods. Absorption
CEA
CEX
a'CEA
Most a'CEX
PCAS*
[r a'CEA (4)
La'CEX (10)
a'CEA (4)
a'CEA (4)
a'CEA (10)
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FIG. 3.-A. Reaction ofidentity between CEX and NGP using anti-CEX (Type 10), and also between
the anti-CEX and anti-NCA although this is partly obscured by impurities.
B. PCA extracts of cancer plasma show both CEA and CEX lines (P3 and P1) or only the CEX
line (P2). Before extraction, P1 and P3 contained 1000 ng per ml ofCEA while P2 contained 136
ng per ml. Lines were enhanced by ICD (Darcy, 1972).
ofCEA with massive amounts ofanti-CEX
weakened the CEA line.
Absorption of CEX preparations with
anti-CEA in massive amounts removed all
CEX. This difference from the preceding
experiment almost certainlyreflectsmerely
the relative strengths of the prepara-
tions. Absorption of the crude colonic
carcinoma extract (PCAS) with anti-CEA
removed the CEA line which it gave with
antiserum Type 3 but left its CEX line.
Massive absorption removed both lines.
When it was absorbed with anti-CEX
the reverse tended to happen but fell
short of completion because of the weak-
ness of the antiserum.
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FIG. 4. Immunoelectrophoresis of CEA (top well) an( CEX (bottom well) with antiserum against
both (Type 1) in the centre trough.
Comparison of CEX with the (CEA-
associated protein of other authors
Fig. 4 shows an immunoelectrophoresis
of CEA along with CEX using rabbit
antiserum Type 1 (Table I). The CEX
gives a short arc which is entirely in the
fl-region (it encircles the origin, mainly on
its y-side). The CEA arc is a long one
which extends from the fl-region to the
x-region and there is a suggestion that it is
a double-humped arc. These results were
obtained on 1% I.D. Oxoid agar at pH
8 2. The same picture was, in its general
features, obtained by others (Mach and
Pusztaszeri, 1972; von Kleist et al., 1972).
An antiserum to her nonspecific cross-
reacting antigen (NCA) was kindly sent
by Dr Sabine von Kleist. This gave a
reaction of identity with our goat anti-
CEX serum, using as antigen our purified
CEX. Likewise, Dr Mach kindly sent Us
a sample of his purified NCGP (normal
glycoprotein). This gave a reaction of
identity with our purified CEX using Type
10 antiserum (Fig. 3A).
Occurrence of (EA and CEX in other
tissues and fluids
Ourfindings are shown in Table III and
IV. The quantitative data are only
approximate and the numbers of " + "
are more logarithmic than arithmetic.
Primary colonic carcinomata have, as a
group, less CEX and CEA than their
metastases; they also have a higher ratio
of CEX to CEA. Normal colon obtained
at autopsy can have a CEX content about
1/10 that of our standard metastatic
extract (PCAS) and a CEA content about
1/20 of it. The other colon specimens,
obtained at operation, contained less of
these antigens.
Primary mammary carcinomata con-
tain more CEX than CEA (which by this
method could not be detected). The
amounts ofCEX are comparable with that
in primary colonic carcinomata. The
occurrence of CEX in normal breast tissue
was uncertain.
Primary bronchial carcinomata also
contain a preponderanceofCEX overCEA.
Normal lung tissue extracts showed little
or no CEX or CEA at the tested concen-
trations. The extract of pooled primary
bladder carcinoma showed (at 50 mg/ml)
some CEX but no CEA.
Foetal tissues from a pool, ranging in
gestational age from 10 to 23 weeks and
tested at the high concentration of
100 mg/ml of the lyophilized dialysed
PCA extract, showed measurable amounts
155156 D. A. DARCY, C. TURBERVILLE AND R. JAMES
TABLE III.-Relative CEX and CEA Content of Various Pathological and Normal
Tissues1
Disorder
Normal colon*
Pooled " normal " colon from 3 patients
with primary colonic carcinomat
Pooled " normal " colon from 3 patients
with primary colonic carcinomat
AMetastatic colonic carcinoma*
Primary colonic carcinomat
Primary mammary carcinomat
" Normal " breast tissue medial to and
distant from primary mammary carciinomat
Primary bronchial carcinoma*
Normal lung*
Primary bladder carcinomat (pooled)
Foetal tissuest (pooled)
gastro-intestinal tract
pancreas
liver
lung
Number of specimens
examined with the
levels shown
1
1
1
1
2
1
1
1
1
1
1
4
3
1
4
1
1
4
lo
Ilo
1
1
1
3 00
1
I
1
1
1
1
Relative amounts
detected of
CEX CEA
+
Trace
Trace
+ + A-(+)
+
+
Trace
0
0
0
0
0
Trace
0
()
0
0 ++
0
Trace
0
Trace
0
0
0
0
0}
0
A-4-
++
Trace
++T++
+4-A
+
+
+
Trace
0
++
+
Trace
Trace
Trace
++ -
++
+
+
Trace
0
+
Trace
1 All are perchloric acid extracts uniless otherwise shown.
* Autopsy specimen.
t Surgical specimen.
o Ammonium sulphate extracts.
oo Saline extracts.
TABLE IV.-Relative CEX and CEA Content of Body Fluids
States
in Various Pathological
Disorder
Normal
Colorectal carcinoma
Colorectal carcinoma
Colorectal carcinoma
Mammary carcinoma
Pancreatic carcinoma
Carcinoma of cervix
Normal
Carcinoma of bladder
Carcinoma of bladder
Carcinoma of bladder
Urinary tract infection
Number of specimens
examined with the
levels shown
3
1
3
1
1
1
3
1
1]
I
IRelative amounts
detected of
CEX CEA
Trace 0
A+I-F ++
+ Trace
Trace 0
+4+A ++
A+-+- +-4
Trace 0
0t )0
Trace
+-+
Body fluid
Plasma
UrineI.MMUNOLOGICAL STUDY OF CARCINOEMBRYONIC ANTIGEN
of CEX and CEA only in the intestinie
and colon; these were about I /5(0 the CEX
content of our stanidard colonic tumotur
PCAS extract and about 1/70 its contenit
ofCEA. Ofthe other foetal tissues testedl
at 100 mg/ml, pancreas alone showed a
trace of CEX and none showed (EA.
Thus, CEX as well as CEA is a foetal
component.
Normal uirine after conceintrationi
showed neither CEX nor CEA by immune
diffusion, but urine from patients with
bladder carcinoma or infections had vary-
ing amounts of CEX and CEA (Table IV).
CEX and CEA were demonstrable in
plasma (Table IVr and Fig 3B). The
amount of CEA estimated by the gel
diffusion method was proportional to the
amount estimated by radioimmunoassay
of the same series of plasmas. CEX was
dletectable in all cancer and normal plasma
tested although sometimes in onlv trace
amounts.
DISCUSSION
We have detected a CEA-associated
antigen in varying amounts in a wide
variety of tumours, including colonic and
mammary carcinomata, normal" adult
and foetal tissues. It has been provision-
ally named CEX to indicate its relation-
ship with CEA. This relationship is best
explained by the following model:
Let CEA be represented as C
and CEX be represented as C-
-A
-X
where C represents antigenic groups com-
mon to both substances and A and X
represent their specific distinguishing anti-
genic groups. Our numerous immuno-
logical findings appear to be explicable on
this basis.
There can be little doubt that each
substance has its own specific antigenic
group(s). The production of specific anti-
sera for each which failed to give a gel-
diffusion line with the other antigein, and
the frequent occurrence of " spurring "
with various anitisera seem to prove this.
The evidence for common antigenic
group(s) comes mainly from reaction of
identity " or ' partial identity". These
were so nutmerotus and clear-cut (Fig. 1B)
that they are unlikely to be accounted for
by the only other plausible explanation,
viz conitaminationi of the purified CEX by
CEA and of the purified CEA by CEX.
Contamination of our CEX by a small
amount of CEA was known; similarly
contamination of our puirified CEA by
abouit 1% of CEX could not be ruled out
althoLugh a separate CEX line was not
demonstrable using the most, sensitive
ID.. methods. To invalidlate the reactions
ofidentity by this explanation, it would be
necessarv to assume a concentration of
the contaminant sufficient to give a
separate line which coincided perfectly
with the existing single line, which did not
exist in our preparations. Separate evi-
dence comes from the antiserum Type 8
(Table I) which was prepared with CEX,
from which all traces of CEA had been
removed by immunoabsorption and con-
firmed by radioimmunoassay. This anti-
serum gave a line with CEX and also
with purified CEA, a finding which is
difficult to explain other than by the
presence of " common " antibody, i.e.,
anti-C. This antiserum would appear to
contain anti-C and anti-X, since it showed
a CEX " spur " but none for CEA. The
otherantisera can besimilarlyprovisionally
classified according to their reactions.
Type-3 antiserum would appear to be anti-
C, anti-A, since it failed to produce a CEX
spur" but gave a CEA one; the CEX
line which it gives must, on this basis, be
produced by anti-C (Fig. IB). The faster
diffusion ofthe CEX line can be accounted
forby itssmaller molecularweight (Turber-
ville et al., 1 973).
With materials fromMachandalsofrom
von Kleist, we have been able to show
reactions of identity between NGP (Mach
and Puisztaszeri, 1972), NCA (von Kleist
et al., 1972) and CEX, and they have
similar electrophoretic patterns. Both
NGP and NCA were isolated from pulmon-
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ary tissue and until chemical identity has
been firmly established, the name CEX
is retained for our material.
Monospecific anti-CEA and CEX anti-
sera could be raised in goats and rabbits
by immunizing with ,ug doses of purified
CEA and partly-purified CEX. Their
monospecificity in gel diffusion suggests
that they contained no anti-C,but themore
sensitive method of massive absorption
(Table III) strongly suggested that they
contained small amounts of anti-C and
possibly small amounts ofantibody to the
specific group of the other protein. That
after a booster dose certain goats produc-
ing anti-CEA by this method gave a faint
CEX line can be explained either by an
increase in the amount of anti-C or by the
appearance of anti-X (due to trace con-
tamination) or to a combination of both.
We were able to show that such antisera
gave the appearance (Fig. 2B) which
suggested to Mach et al. (1972) that they
should be absorbed with PCA extract of
normal colon before being used in radio-
immunoassay ofCEA.
Thisraises the questionofwhetherCEX
can interfere in the radioimmunoassay of
CEA. We have demonstrated that CEX
is present in all human plasmas tested and
probably in greater quantity than CEA.
We have evidence that CEX has an anti-
genic group or groups in common with
CEA. Yet we have observed that our
CEX which had been further purified by
treatment with an anti-CEA immuno-
absorbant was registered as CEA-free by
our radioimmunoassay, while it still gave
a strong CEX line in gel diffusion. The
answer must lie in the nature of the anti-
serum and the difference between the two
tests. The antiserum used in our CEA
radioimmunoassay was of the type which
gave no CEX line and hence contained, at
best, only trace amounts of antibody to
CEX. This may be a sufficient explana-
tion of the failure of CEX to interfere.
There is also the possibility that the two
tests differ in nature, that the radioimmu-
noassay, employing as it does high-affinity
antibody (which may attach to the CEA
molecule by both its " arms "), may not
be a precipitin reaction.
The results obtained by the different
methods of immunization require com-
ment. One problem is why a monospecific
anti-CEX was produced by a ,tg immuniz-
ation schedule while the same immunogen
in lug doses produced a mixed anti-CEX,
anti-CEA. This may be because the
larger dose evoked anti-C antibodies (or
more of them) or possibly anti-A anti-
bodies against the contaminating CEA
(although there was no CEA " spur " to
support this idea). Certainly in ,ug
immunization with purified CEA and CEX
the specific antigen groups A and X are
considerably stronger immunogens than C.
The answer to the question why one
type of antiserum (No. 3, Table I) gave
separate CEX and CEA lines in contrast
to all the others must lie in the nature of
its immunogen which was an extract
particularly strong in both CEX and CEA.
It might be expected to evoke a strong
antibody response to each, and in parti-
cular to the common antigenic groups
(which would be summated). Such a
strong antigen-antibody system would
give a better opportunity for the two lines
to become separated. It was observed
that even with this system the lines
separated only at certain ratios of anti-
serum to antigen, called loosely " equiva-
lence " since the lines were then at their
sharpest. The failure of the other biva-
lent antisera to show two separate lines
could be due either to a coincidence ofthe
two lines or to a genuine common line. In
general, the weakness of these antisera
hindered the study of this question but
numerous experiments failed to " split"
the single line.
The apparently paradoxical results of
the " massive" absorptions shown in
Table II can be adequately explained
either by the presence of contamination
of the absorbing antigen with the other
antigen or to the common antigen group(s),
or to both. When absorption failed to
reach completion this was apparently
because the technical limits of the test
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had been reached. The fact that purified
CEA could be partly absorbed by anti-
CEXsuggeststhatthis antiserumcontained
some anti-C and possibly some anti-A.
The phenomenon of a double CEA line
(not CEX) produced early in immunization
by at least one of the goats (Fig. 2A) and
one ofthe rabbits is ofinterest. It implies
that CEA exists in (at least) two molecular
forms, differing either in molecular weight
or in antigenicity or both. That there
is a size difference is suggested by the
column fractionation evidence. That there
may also be antigenic difference is sug-
gested by the fact that neither line could
prevent some anti-CEA antibody from
passing through it and precipitating the
other CEA behind it. It is of possible
relevance that the immunoelectrophoresis
arc for CEA showed a suggestion of a
double-hump (Fig. 4), i.e., of having a fast
and a slow portion which were to some
extent distinct.
Biologically the distribution of CEA
and CEX is very similar. Neither is
confined to neoplastic or foetal tissues
although they are present in larger
amounts in pathological tissues (Table
III), thus confirming similar findings by
Martin et al., 1972; Burtin et al., 1972 and
Rosai, Tillach and Marchesi, 1972). We
have also found them in larger amounts in
the body fluids of patients with a variety
of tumours (Table IV). Further, we have
observed that their immunologically deter-
mined titre may be higher in autopsy than
in surgical specimens, which suggests that
autolysis may play a role in their recover-
ability.
Our findings of CEX in some tissues
and fluids without accompanying CEA
(Table III and IV) can be explained by
the relative insensitivity of gel diffusion
methods, which can detect only about 103
the amount measurable by radioimmuno-
assay and by the fact that CEX is nearly
always present in greater amounts than
CEA. Neither CEA nor CEX is thus
cancer specific (Tables III and IV; Hall
et al., 1972; Laurence et al., 1972). More-
over, absorption of Type 4 antiserum
(monospecific anti-CEA) with PCA ex-
tracts of normal colon did not leave a
cancer-specific antiserum but, depending
on the extract chosen, the resulting anti-
serum could have either no antibody
activity or else have its anti-CEA activity
slightly weakened. The absence of com-
plete cancer specificity limits the differen-
tial diagnostic potential of CEA measure-
ment in blood (Martin et al., 1972;
Laurence et al., 1972; LoGerfo et al.,
1972; Zamchek et al., 1972) and in urine
(Hall et al., 1972).
However, it is possible that CEX may
prove to be a clinically valuable tumour-
associated molecule for which a radio-
immunoassay capable of measuring it in
small amounts should be established. In
favour ofthis course ofaction is the finding
that CEX appears to be no less specific
than CEA and is always present in higher
amounts in blood and usually in urine, so
that it can be measured more readily. On
this account, too, elevation of CEX level
in body fluids may be detectable earlier.
On the other hand, its use as an aid to
diagnosis or monitoring of therapy will
depend on its levels in body fluids in associ-
ation with inflammatory or regenerative
disorders. Its higher level in normal tissue
and plasma than CEA may mean that a
wider range of values will be found in
neoplastic and non-neoplastic disorders
than occur with CEA.
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